Feedback / Questions
dendrimer N-acetyl-cysteine (OP-101) - Ashvattha Therap
https://www.businesswire.com/news/home/20200528005275/en/Ashvattha-Therapeutics-Subsidiary-Orpheris-Announces-FDA-Agreement
May 28, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev